Wenlong Tan Selected Research

RX 0047

7/2019

Azoreductase-Responsive Metal-Organic Framework-Based Nanodrug for Enhanced Cancer Therapy via Breaking Hypoxia-induced Chemoresistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenlong Tan Research Topics

Disease

5	Neoplasms (Cancer) 03/2021 - 11/2013
4	Breast Neoplasms (Breast Cancer) 03/2021 - 11/2013
2	Infections 01/2016 - 11/2013
2	Stomach Neoplasms (Stomach Cancer) 06/2014 - 03/2014
1	Hypoxia (Hypoxemia) 07/2019
1	Carcinogenesis 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Flavivirus Infections 01/2016
1	Diarrhea 05/2014
1	Chronic Hepatitis B 11/2013

Drug/Important Bio-Agent (IBA)

5	Trastuzumab (Herceptin)FDA Link 07/2014 - 11/2013
3	Pharmaceutical PreparationsIBA 07/2019 - 11/2013
2	Biomarkers (Surrogate Marker)IBA 02/2018 - 01/2017
2	pertuzumabIBA 05/2014 - 11/2013
1	MicroRNAs (MicroRNA)IBA 03/2021
1	Oxygen (Dioxygen)IBA 07/2019
1	azoreductaseIBA 07/2019
1	RX 0047IBA 07/2019
1	Metal-Organic FrameworksIBA 07/2019
1	Small Interfering RNA (siRNA)IBA 07/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2019
1	Proteins (Proteins, Gene)FDA Link 07/2019
1	Long Noncoding RNAIBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2016
1	EpitopesIBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2014
1	LigandsIBA 07/2014
1	Cetuximab (Erbitux)FDA Link 06/2014
1	Lapatinib (GW572016)FDA Link 05/2014
1	saracatinibIBA 03/2014
1	InterferonsIBA 11/2013
1	Reverse Transcriptase InhibitorsIBA 11/2013
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2013

Therapy/Procedure

3	Therapeutics 07/2019 - 03/2014
1	Drug Therapy (Chemotherapy) 07/2019